EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

Barbara Eichhorst iD, Paolo Ghia iD, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P Kater iD, Carsten U Niemann, Sarka Pospisilova, Tadeusz Robak, Anna Schuh, Kostas Stamatopoulos und 2 weitere

HemaSphere · 2026-06 · 10 (6)

DOI: 10.1002/hem3.70403 ↗

Kurz gefasst

Leitlinie in der Zeitschrift HemaSphere, online erschienen am 10.06.2026. Verfasst von Barbara Eichhorst und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department I for Internal Medicine, Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf University of Cologne Cologne Germany. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL. The current, 2026 edition, represents the new, updated guidelines that, for the first time (and in agreement with ESMO), were written on behalf of the European Hematology Association (EHA), which will be solely responsible for subsequent editions, published annually to keep pace of the fast‐moving field of CLL research and clinical applications. The new guidelines support approaching the management of CLL in a more holistic fashion, from the initial diagnosis (including active surveillance) to treatment need, with particular emphasis on the interplay between disease‐ and patient‐specific criteria for decision‐making, to the latest stage of possible Richter transformation, which is now specifically mentioned in the title of the guidelines. These new recommendations are the result of a consensus reached among medical experts from several European countries and, for the first time, have involved patient advocacy representatives, which is in line with EHA standard operating procedures for clinical practice guideline development. Updates in terms of treatment options include the recently European Medicines Agency‐approved, time‐limited combination therapy acalabrutinib and venetoclax ± obinutuzumab as first‐line treatment, and continuous pirtobrutinib for patients exposed to covalent Bruton's tyrosine kinase inhibitors in the relapsed/refractory setting.

Autor:innen und Institutionen

  • Department I for Internal Medicine, Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf University of Cologne Cologne Germany.
  • Medical School Università Vita-Salute San Raffaele Milano Italy.
  • IRCCS Ospedale San Raffaele Comprehensive Cancer Center Milano Italy.
  • Department of Hematology, University Hospital Vall d'Hebron Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.
  • Department of Haematology, Cancer Services University Hospital Limerick Limerick Ireland.
  • Limerick Digital Cancer Research Center, Health Research Institute, School of Medicine University of Limerick Limerick Ireland.

ORCID-Profile: Barbara Eichhorst, Paolo Ghia, Arnon P Kater

Zitieren

APA

Eichhorst, B., Ghia, P., Bosch, F., Clifford, R., Gregor, M., Guieze, R., Kater, A. P., Niemann, C. U., Pospisilova, S., Robak, T., Schuh, A., Stamatopoulos, K., Tadmor, T., & York, N. (2026). EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation. HemaSphere, 10(6). https://doi.org/10.1002/hem3.70403

Vancouver

Eichhorst B, Ghia P, Bosch F, Clifford R, Gregor M, Guieze R, et al. EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation. HemaSphere. 2026;10(6). doi:10.1002/hem3.70403

BibTeX
@article{Eichhorst2026,
  author = {Eichhorst, Barbara and Ghia, Paolo and Bosch, Francesc and Clifford, Ruth and Gregor, Michael and Guieze, Romain and Kater, Arnon P and Niemann, Carsten U and Pospisilova, Sarka and Robak, Tadeusz and Schuh, Anna and Stamatopoulos, Kostas and Tadmor, Tamar and York, Nick},
  title = {EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation},
  journal = {HemaSphere},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1002/hem3.70403}
}
Kostenlos starten →